Relapse Rate in an Inflammatory Disease of Breast Treated by Pharmaceutical and Surgical Approaches

Comparison of Relapse in Idiopathic Granulomatous Mastitis patients treated either by pharmaceutical or surgical approaches

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT2013123015999N1

Enrollment

Registered

2014-01-27

Start date

2012-05-11

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Idiopathic Granulomatous Mastitis. Inflammatory disorders of breast

Interventions

Intervention 1: Intervention : Azithromycin and Prednisolone concomitant application of Azithromycin (250 milligram twice per week) and Prednisolone (40 milligram daily). Afterwards the protoc

Treatment - Drugs

Treatment - Surgery

Intervention : Azithromycin and Prednisolone concomitant application of Azithromycin (250 milligram twice per week) and Prednisolone (40 milligram daily). Afterwards the protocol suggested Pre

control:Partial mastectomy

Eligibility

Sex/Gender

Female

Age

7 Years to 65 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Women who are well documented Idiopathic Granulomatous Mastitis (IGM) patients via pathological finding, IGM patient being not treated Exclusion criteria: Dissuasion of individuals for treatment procedures.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Relapse. Timepoint: Patients were monthly examined for 15 months (from initiation of the intervention to 6 months after cessation of the intervention). Method of measurement: physical examination.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Roya Taleban

Isfahan University of Medical Sciences

r.taleban@med.mui.ac.ir+98 31 1792 2542

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026